Clinical Technology

Adult Immunization

MASLD/MASH

Hepatitis

Hepatology

Pediatric Immunization

Colorectal Cancer

Renal Cancer

Lung Cancer

Melanoma

Skin cancer

Prostate Cancer

Breast Cancer

Cervical Cancer

Screening

PTSD

Psychosis

Panic Disorder  

Anxiety

Eating Disorders

Depression

Substance-related Disorders

ADHD

Psychiatry 

Food Allergies

Anaphylaxis

Seasonal Allergies

Allergy

Osteoporosis

Menopause

Pregnancy and Birth

Women's Health

Heart Failure

Atrial Fibrillation

Lipid disorders

Hypertension

Cardiology

Pediatrics

Psoriasis

Rosacea

Atopic Dermatitis

Dermatology

Adrenal Disorders

Thyroid Disorders 

Diabetes

Endocrinology 

Fibromyalgia

Pain Management

GERD

C Difficile Infection

Celiac disease

Irritable Bowel Syndrome 

Inflammatory Bowel Disease

Gastroenterology

Coronavirus

Hepatitis C

Influenza

HIV AIDS

Pneumonia

Sexually transmitted infections

Infectious Disease

Obesity Medicine

Psoriatic arthritis

Lupus

Rheumatoid Arthritis

Osteoarthritis

Gout

Rheumatology

Chronic Kidney Disease

Nephrology

Epilepsy

Cerebrovascular Diseases

Parkinson Disease

Alzheimer Disease/Dementia

Mental Health

Headache

Migraine

Sleep Disorders

Neurology

Pulmonary hypertension

Interstitial lung disease

Asthma

Cystic Fibrosis

COPD

Pulmonology

News

All News

Editorial Podcasts

Practice Management

Video Interviews

Media

Around the Practice

Between the Lines

ConsultantLive

Frontline Insights

Institutional Insights

Primary View

Provider Toolkits

Screening Series

Conferences

Conference Coverage

Conference Listing

Product Theater Recaps

Resources

Interactive Posters

Product Profile

Publications

Subscribe

CE/CME

Patient Care Online offers clinical news and resources for primary care clinicians, focusing on disease states, guidelines, and trends to improve care.

About Us

Advertise

Contact Us

Editorial Board

Terms and Conditions

Privacy

Do Not Sell My Information

Patient Care Online – Primary Care News and Clinical Resources

Facebook

LinkedIn

Clinical Focus

Allergy & Immunology

Endocrinology

Men’s Health

Psychiatry

Women’s Health

Business Focus

Billing and Collections

Career Planning

Coding and Documentation

Concierge Medicine

Cybersecurity

EHRs

Investing

Patient Relations

Personal Finance

Remote Patient Monitoring

Staffing

Technology

Telehealth

Value-based Care

Spotlight

VMS and Menopause

Atopic Dermatitis Provider Toolkit

Adult Immunization Provider Toolkit

Dermatology Hot Topics

1rem

Clinical Topics

Topics

Podcasts

Linda Stein Gold, MD, reviews AAD’s 2025 updates on new topical and biologic options for adult atopic dermatitis.

2025 AAD Atopic Dermatitis Update: Linda Stein Gold, MD, on New Topical and Biologic Therapies

, we cover a range of studies impacting clinical practice. We discuss patient preferences for atopic dermatitis treatment, how active transportation like cycling reduces the risk of dementia, and new findings on the safety of childhood vaccines and aluminum exposure. We also explore the link between maternal depression and parenting practices, highlighting the importance of mental health support for mothers. Tune in for these important insights shaping patient care across multiple specialties.

Editor's note: Episode timestamps produced using AI tools.

Healthcare Professionals’ Views on Nutrition and Supplements (00:00:11):


Survey results on supplements, diets, food safety, nutritional training, and challenges in nutrition counseling among healthcare professionals.

Transportation Choices and Dementia Risk (00:01:33):


Study on how cycling and mixed walking reduce dementia risk, while walking alone may increase Alzheimer’s risk.

Alzheimer Disease, Tau Pathologies, and Late-Life Mood Disorders (00:01:33):


Research linking tau accumulation and amyloid deposits to late-life depression and mood disorders in older adults.

Aluminum Exposure from Childhood Vaccines and Health Risks (00:02:59):


Large-scale study finds no link between aluminum in vaccines and autoimmune, allergic, or neurodevelopmental disorders.

Impact of Maternal Depression on Parenting and Child Development (00:04:16):


Systematic review shows maternal depression negatively affects parenting and child development, especially in early years.

Insights on atopic dermatitis treatment preferences, the safety of childhood vaccines, maternal depression’s effect on parenting, and more.

The Weekly Dose: Pediatric Vaccine Safety, Atopic Dermatitis, Dementia Risk, and Maternal Depression

, we cover a wide range of important clinical findings. We discuss the feasibility of digital cognitive assessments for Alzheimer screening in primary care, patient preferences for atopic dermatitis treatments, and the impact of social determinants of health on hormonal therapy use among midlife women. Additionally, we explore the FDA's Breakthrough Device designation for a multi-cancer detection test and new findings linking the quality of low-carb and low-fat diets to coronary heart disease prevention. Tune in for these key insights that are shaping clinical practice.

Discover essential clinical insights on Alzheimer disease screening in primary care, eczema treatments, and the latest in cancer detection and diet impacts on CHD risk.

The Weekly Dose: Clinical Updates on Cancer Detection, Cognitive Screening, CVD Prevention, Atopic Dermatitis Treatment

, we dive into the most impactful clinical research from the past week on 

, covering key studies across multiple specialties. We begin with a study on the treatment of bacterial vaginosis, highlighting the significant impact of antimicrobial therapy for male partners in reducing recurrence rates. Next, we explore a meta-analysis on the use of dupilumab in treating atopic dermatitis in children, showcasing its effectiveness in reducing disease severity and pruritus. We also cover a groundbreaking study on colorectal cancer risk models for adults aged under 45 years, introducing new ways to personalize screening strategies.

Additionally, we discuss the EKSTROM trial, which presents data on colchicine’s role in stabilizing coronary plaque and reducing cardiovascular risk. Finally, we look at the FDA’s approval of dupilumab for chronic spontaneous urticaria, offering new hope for patients with persistent symptoms despite antihistamine treatment.


PODCAST: Listen to our first episode for new research on bacterial vaginosis, a new treatment option for chronic urticaria, and more. 

Weekly Dose: A Roundup of Top Stories for Primary Care Physicians

Psoriasis, lichen planus, and pityriasis rosea share overlapping presentations and comorbidities, but distinct pathophysiologies require accurate diagnosis and tailored therapeutic approaches.

Evidence-Based Management of Papulosquamous Disorders in Primary Care

The approval of roflumilast 0.05% provides a steroid-free, once-daily treatment option for safe and effective long-term management of pediatric eczema. 


FDA Expands Indication for Roflumilast to Treat Atopic Dermatitis in Children Aged 2 to 5 Years

Remibrutinib is the first oral BTK inhibitor for chronic spontaneous urticaria, with a dual mechanism of action that blocks 2 key autoimmune mechanisms. 

Novartis' Oral Targeted BTKi Treatment Approved for Chronic Spontaneous Urticaria in Adults 

The FDA has approved guselkumab for children aged 6 years and older with moderate to severe plaque psoriasis or active psoriatic arthritis, making it the first IL-23 inhibitor authorized for pediatric use.

FDA Approves Guselkumab for Pediatric Plaque Psoriasis and Active Psoriatic Arthritis

Patient Care tapped the rich trove of research and expert perspectives from the Revolutionizing Atopic Dermatitis 2025 conference to create a snapshot of the AD care of the future.

Atopic Dermatitis: The Pipeline and Clinical Approaches That Could Transform the Standard of Care 

Dermatology

Latest News